Testing pregnant women for GBS during labor is critical for targeted prevention.. The Mirai Genomics solution uses a patented PCR-based SmartAmp technology, ensuring rapid and reliable results. The process involves a brief vaginal/rectal swab specimen preparation in test tubes, transferring the prepared solution into a cartridge, and running the reaction in the GenePad device. This streamlined system offers ease of use, accuracy, and speed, making it a highly effective tool for improving maternal and neonatal outcomes during delivery.